Authors:
Ben-Ari, Z
Mor, E
Shapira, Z
Tur-Kaspa, R
Citation: Z. Ben-ari et al., Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation, LIVER TRANS, 7(2), 2001, pp. 113-117
Citation: J. Lampel et Z. Shapira, Judgmental errors, interactive norms, and the difficulty of detecting strategic surprises, ORGAN SCI, 12(5), 2001, pp. 599-611
Authors:
Ben-Ari, Z
Mor, E
Manhaim, V
Barak, O
Bar-Nathan, N
Shaharabani, E
Shapira, Z
Tur-Kaspa, R
Citation: Z. Ben-ari et al., Passive immunization with OMRI-Hep-B for prevention of hepatitis B virus reinfection after liver transplantation, TRANSPLAN P, 33(6), 2001, pp. 2895-2896
Authors:
Chkhotua, A
Shapira, Z
Tovar, A
Shabtai, E
Yussim, A
Citation: A. Chkhotua et al., Cellular senescence: A new marker of kidney function recovery after ischemic injury in rats, TRANSPLAN P, 33(6), 2001, pp. 2910-2915
Authors:
Mor, E
Cohen, J
Erez, E
Grozovsky, A
Shaharabani, E
Bar-Nathan, N
Yussim, A
Micowiz, R
Shapira, Z
Zinger, P
Citation: E. Mor et al., Short intensive care unit stay reduces septic complications and improves outcome after liver transplantation, TRANSPLAN P, 33(6), 2001, pp. 2939-2940
Authors:
Mor, E
Shaharabani, E
Ben-Ari, Z
Bar-Nathan, N
Yussim, A
Shapira, R
Tur-Kaspa, R
Shapira, Z
Citation: E. Mor et al., Experience with 100 liver transplant recipients at the Rabin Medical Center and Schneider Children's Medical Center, TRANSPLAN P, 33(6), 2001, pp. 2943-2944
Authors:
Mor, E
Michowiz, R
Ashkenazi, T
Shabtai, E
Nakache, R
Eid, A
Hoffman, A
Mizrahi, S
Shabtai, M
Shapira, Z
Citation: E. Mor et al., Extension of the organ pool in kidney transplantation: First year experience of the Israel Transplant Center, ISR MED ASS, 2(4), 2000, pp. 302-305
Citation: Z. Shapira et A. Yussim, Fifth annual congress of the Transplantation Society of Israel - Introduction, TRANSPLAN P, 32(4), 2000, pp. 677-677
Authors:
Mor, E
Lustig, S
Tovar, A
Bar-Nathan, N
Shharabani, E
Shapira, Z
Yusim, A
Citation: E. Mor et al., Thrombotic microangiopathy early after kidney transplantation: Hemolytic uremic syndrome or vascular rejection?, TRANSPLAN P, 32(4), 2000, pp. 686-687
Authors:
Klein, T
Shapira, Z
Nathan, NB
Shaharabani, E
Or, H
Zakai, C
Shabtai, E
Yussim, A
Citation: T. Klein et al., Lack of correlation between HLA match and long-term survival in living donor kidney transplantation, TRANSPLAN P, 32(4), 2000, pp. 692-693
Authors:
Mor, E
Bar-Nathan, N
Shapira, R
Simchi, E
Shaharabani, E
Yusim, A
Zehavi, I
Sheinfeld, T
Ben-Ari, Y
Dinari, G
Shapira, Z
Citation: E. Mor et al., Liver transplantation in children: Experience at Schneider's Children's Medical Center, Israel, TRANSPLAN P, 32(4), 2000, pp. 704-705
Authors:
Ben-Ari, Z
Mor, E
Shaharabani, E
Bar-Nathan, N
Shapira, Z
Tur-Kaspa, R
Citation: Z. Ben-ari et al., Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy, TRANSPLAN P, 32(4), 2000, pp. 709-710
Authors:
Ben-Ari, Z
Mor, E
Shaharabani, E
Bar-Nathan, N
Shapira, Z
Tur-Kaspa, R
Citation: Z. Ben-ari et al., Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation, TRANSPLAN P, 32(4), 2000, pp. 714-716
Authors:
Kogan, A
Singer, P
Cohen, J
Grozovski, E
Grunberg, G
Mor, E
Shapira, Z
Citation: A. Kogan et al., Readmission to an intensive care unit following liver and kidney transplantation: A 50-month study, TRANSPLAN P, 31(4), 1999, pp. 1892-1893